APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antidiabetic Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antidiabetic Drug Industry Growth and Trends Forecast to 2032

19 December 2025103 pages

Choose your research edition.

Industry ResearchAntidiabetic Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Antidiabetic Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Antidiabetic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antidiabetic Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Antidiabetic Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Antidiabetic Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antidiabetic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antidiabetic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antidiabetic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antidiabetic Drug include Takeda, Eli Lilly, Pfizer, Wockhardt, Tonghua Dongbao, Sanofi-Aventis, Oramed, Novo Nordisk and Halozyme Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antidiabetic Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antidiabetic Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antidiabetic Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antidiabetic Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antidiabetic Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antidiabetic Drug Market by Company

Takeda

Eli Lilly

Pfizer

Wockhardt

Tonghua Dongbao

Sanofi-Aventis

Oramed

Novo Nordisk

Halozyme Therapeutics

Bristol-Myers Squibb

Boehringer Ingelheim

Biocon

Antidiabetic Drug Segment by Type

Dpp-4 Inhibitors

Glp-1 Agonist

Alpha-Glucosidase Inhibitors

Sglt–2

Thiazolodinediones

Meglitinides

Biguanides, Sulphonylureas

Antidiabetic Drug Segment by Application

Type I Diabetes

Type II Diabetes

Antidiabetic Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidiabetic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antidiabetic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidiabetic Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antidiabetic Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antidiabetic Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Dpp-4 Inhibitors Table 2. Major Company of Glp-1 Agonist Table 3. Major Company of Alpha-Glucosidase Inhibitors Table 4. Major Company of Sglt–2 Table 5. Major Company of Thiazolodinediones Table 6. Major Company of Meglitinides Table 7. Major Company of Biguanides, Sulphonylureas Table 8. Global Antidiabetic Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Antidiabetic Drug Sales by Type (2021-2026) & (K Units) Table 10. Global Antidiabetic Drug Sales Market Share in Volume by Type (2021-2026) Table 11. Global Antidiabetic Drug Sales by Type (2021-2026) & (US$ Million) Table 12. Global Antidiabetic Drug Sales Market Share in Value by Type (2021-2026) Table 13. Global Antidiabetic Drug Price by Type (2021-2026) & (US$/Unit) Table 14. Global Antidiabetic Drug Sales by Type (2027-2032) & (K Units) Table 15. Global Antidiabetic Drug Sales Market Share in Volume by Type (2027-2032) Table 16. Global Antidiabetic Drug Sales by Type (2027-2032) & (US$ Million) Table 17. Global Antidiabetic Drug Sales Market Share in Value by Type (2027-2032) Table 18. Global Antidiabetic Drug Price by Type (2027-2032) & (US$/Unit) Table 19. North America Antidiabetic Drug Sales by Type (2021-2026) & (K Units) Table 20. North America Antidiabetic Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Antidiabetic Drug Sales by Type (2021-2026) & (K Units) Table 22. Europe Antidiabetic Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Antidiabetic Drug Sales by Type (2021-2026) & (K Units) Table 24. Asia-Pacific Antidiabetic Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Antidiabetic Drug Sales by Type (2021-2026) & (K Units) Table 26. Latin America Antidiabetic Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Antidiabetic Drug Sales by Type (2021-2026) & (K Units) Table 28. Middle East and Africa Antidiabetic Drug Sales by Type (2021-2026) & (US$ Million) Table 29. Antidiabetic Drug Industry Trends Table 30. Antidiabetic Drug Industry Drivers Table 31. Antidiabetic Drug Industry Opportunities and Challenges Table 32. Antidiabetic Drug Industry Restraints Table 33. Global Antidiabetic Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Antidiabetic Drug Revenue Market Share by Company (2021-2026) Table 35. Global Antidiabetic Drug Sales by Company (2021-2026) & (K Units) Table 36. Global Antidiabetic Drug Sales Share by Company (2021-2026) Table 37. Global Antidiabetic Drug Market Price by Company (2021-2026) & (US$/Unit) Table 38. Global Antidiabetic Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Antidiabetic Drug Major Company Production Sites and Headquarters Table 40. Global Antidiabetic Drug Company, Product Type & Application Table 41. Global Antidiabetic Drug Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Antidiabetic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Antidiabetic Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Antidiabetic Drug Sales by Region (2021-2026) & (K Units) Table 46. Global Antidiabetic Drug Sales Market Share in Volume by Region (2021-2026) Table 47. Global Antidiabetic Drug Sales by Region (2021-2026) & (US$ Million) Table 48. Global Antidiabetic Drug Sales Market Share in Value by Region (2021-2026) Table 49. Global Antidiabetic Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 50. Global Antidiabetic Drug Sales by Region (2027-2032) & (K Units) Table 51. Global Antidiabetic Drug Sales Market Share in Volume by Region (2027-2032) Table 52. Global Antidiabetic Drug Sales by Region (2027-2032) & (US$ Million) Table 53. Global Antidiabetic Drug Sales Market Share in Value by Region (2027-2032) Table 54. Global Antidiabetic Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 55. Global Antidiabetic Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Antidiabetic Drug Sales by Application (2021-2026) & (K Units) Table 57. Global Antidiabetic Drug Sales Market Share in Volume by Application (2021-2026) Table 58. Global Antidiabetic Drug Sales by Application (2021-2026) & (US$ Million) Table 59. Global Antidiabetic Drug Sales Market Share in Value by Application (2021-2026) Table 60. Global Antidiabetic Drug Price by Application (2021-2026) & (US$/Unit) Table 61. Global Antidiabetic Drug Sales by Application (2027-2032) & (K Units) Table 62. Global Antidiabetic Drug Sales Market Share in Volume by Application (2027-2032) Table 63. Global Antidiabetic Drug Sales by Application (2027-2032) & (US$ Million) Table 64. Global Antidiabetic Drug Sales Market Share in Value by Application (2027-2032) Table 65. Global Antidiabetic Drug Price by Application (2027-2032) & (US$/Unit) Table 66. North America Antidiabetic Drug Sales by Application (2021-2026) & (K Units) Table 67. North America Antidiabetic Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Antidiabetic Drug Sales by Application (2021-2026) & (K Units) Table 69. Europe Antidiabetic Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Antidiabetic Drug Sales by Application (2021-2026) & (K Units) Table 71. Asia-Pacific Antidiabetic Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Antidiabetic Drug Sales by Application (2021-2026) & (K Units) Table 73. Latin America Antidiabetic Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Antidiabetic Drug Sales by Application (2021-2026) & (K Units) Table 75. Middle East and Africa Antidiabetic Drug Sales by Application (2021-2026) & (US$ Million) Table 76. Takeda Company Information Table 77. Takeda Business Overview Table 78. Takeda Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Takeda Antidiabetic Drug Product Portfolio Table 80. Takeda Recent Development Table 81. Eli Lilly Company Information Table 82. Eli Lilly Business Overview Table 83. Eli Lilly Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Eli Lilly Antidiabetic Drug Product Portfolio Table 85. Eli Lilly Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Pfizer Antidiabetic Drug Product Portfolio Table 90. Pfizer Recent Development Table 91. Wockhardt Company Information Table 92. Wockhardt Business Overview Table 93. Wockhardt Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Wockhardt Antidiabetic Drug Product Portfolio Table 95. Wockhardt Recent Development Table 96. Tonghua Dongbao Company Information Table 97. Tonghua Dongbao Business Overview Table 98. Tonghua Dongbao Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Tonghua Dongbao Antidiabetic Drug Product Portfolio Table 100. Tonghua Dongbao Recent Development Table 101. Sanofi-Aventis Company Information Table 102. Sanofi-Aventis Business Overview Table 103. Sanofi-Aventis Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Sanofi-Aventis Antidiabetic Drug Product Portfolio Table 105. Sanofi-Aventis Recent Development Table 106. Oramed Company Information Table 107. Oramed Business Overview Table 108. Oramed Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Oramed Antidiabetic Drug Product Portfolio Table 110. Oramed Recent Development Table 111. Novo Nordisk Company Information Table 112. Novo Nordisk Business Overview Table 113. Novo Nordisk Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Novo Nordisk Antidiabetic Drug Product Portfolio Table 115. Novo Nordisk Recent Development Table 116. Halozyme Therapeutics Company Information Table 117. Halozyme Therapeutics Business Overview Table 118. Halozyme Therapeutics Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Halozyme Therapeutics Antidiabetic Drug Product Portfolio Table 120. Halozyme Therapeutics Recent Development Table 121. Bristol-Myers Squibb Company Information Table 122. Bristol-Myers Squibb Business Overview Table 123. Bristol-Myers Squibb Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Bristol-Myers Squibb Antidiabetic Drug Product Portfolio Table 125. Bristol-Myers Squibb Recent Development Table 126. Boehringer Ingelheim Company Information Table 127. Boehringer Ingelheim Business Overview Table 128. Boehringer Ingelheim Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Boehringer Ingelheim Antidiabetic Drug Product Portfolio Table 130. Boehringer Ingelheim Recent Development Table 131. Biocon Company Information Table 132. Biocon Business Overview Table 133. Biocon Antidiabetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Biocon Antidiabetic Drug Product Portfolio Table 135. Biocon Recent Development Table 136. North America Antidiabetic Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. North America Antidiabetic Drug Sales by Country (2021-2026) & (K Units) Table 138. North America Antidiabetic Drug Sales Market Share by Country (2021-2026) Table 139. North America Antidiabetic Drug Sales Forecast by Country (2027-2032) & (K Units) Table 140. North America Antidiabetic Drug Sales Market Share Forecast by Country (2027-2032) Table 141. North America Antidiabetic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Antidiabetic Drug Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Antidiabetic Drug Market Share by Country (2021-2026) Table 144. North America Antidiabetic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Antidiabetic Drug Market Share Forecast by Country (2027-2032) Table 146. Europe Antidiabetic Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Europe Antidiabetic Drug Sales by Country (2021-2026) & (K Units) Table 148. Europe Antidiabetic Drug Sales Market Share by Country (2021-2026) Table 149. Europe Antidiabetic Drug Sales Forecast by Country (2027-2032) & (K Units) Table 150. Europe Antidiabetic Drug Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Antidiabetic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Antidiabetic Drug Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Antidiabetic Drug Market Share by Country (2021-2026) Table 154. Europe Antidiabetic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Antidiabetic Drug Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Antidiabetic Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Antidiabetic Drug Sales by Country (2021-2026) & (K Units) Table 158. Asia-Pacific Antidiabetic Drug Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Antidiabetic Drug Sales Forecast by Country (2027-2032) & (K Units) Table 160. Asia-Pacific Antidiabetic Drug Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Antidiabetic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Antidiabetic Drug Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Antidiabetic Drug Market Share by Country (2021-2026) Table 164. Asia-Pacific Antidiabetic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Antidiabetic Drug Market Share Forecast by Country (2027-2032) Table 166. Latin America Antidiabetic Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Latin America Antidiabetic Drug Sales by Country (2021-2026) & (K Units) Table 168. Latin America Antidiabetic Drug Sales Market Share by Country (2021-2026) Table 169. Latin America Antidiabetic Drug Sales Forecast by Country (2027-2032) & (K Units) Table 170. Latin America Antidiabetic Drug Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Antidiabetic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Antidiabetic Drug Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Antidiabetic Drug Market Share by Country (2021-2026) Table 174. Latin America Antidiabetic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Antidiabetic Drug Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Antidiabetic Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Antidiabetic Drug Sales by Country (2021-2026) & (K Units) Table 178. Middle East and Africa Antidiabetic Drug Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Antidiabetic Drug Sales Forecast by Country (2027-2032) & (K Units) Table 180. Middle East and Africa Antidiabetic Drug Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Antidiabetic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Antidiabetic Drug Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Antidiabetic Drug Market Share by Country (2021-2026) Table 184. Middle East and Africa Antidiabetic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Antidiabetic Drug Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Antidiabetic Drug Distributors List Table 189. Antidiabetic Drug Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Antidiabetic Drug Image Figure 2. Global Antidiabetic Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antidiabetic Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Antidiabetic Drug Sales (2021-2032) & (K Units) Figure 5. Dpp-4 Inhibitors Image Figure 6. Global Dpp-4 Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 7. Glp-1 Agonist Image Figure 8. Global Glp-1 Agonist Sales YoY Growth (2021-2032) & (K Units) Figure 9. Alpha-Glucosidase Inhibitors Image Figure 10. Global Alpha-Glucosidase Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 11. Sglt–2 Image Figure 12. Global Sglt–2 Sales YoY Growth (2021-2032) & (K Units) Figure 13. Thiazolodinediones Image Figure 14. Global Thiazolodinediones Sales YoY Growth (2021-2032) & (K Units) Figure 15. Meglitinides Image Figure 16. Global Meglitinides Sales YoY Growth (2021-2032) & (K Units) Figure 17. Biguanides, Sulphonylureas Image Figure 18. Global Biguanides, Sulphonylureas Sales YoY Growth (2021-2032) & (K Units) Figure 19. Global Antidiabetic Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Antidiabetic Drug Market Share by Type 2025 VS 2032 Figure 21. North America Antidiabetic Drug Sales Market Share in Volume by Type in 2025 Figure 22. North America Antidiabetic Drug Sales Market Share in Value by Type in 2025 Figure 23. Europe Antidiabetic Drug Sales Market Share in Volume by Type in 2025 Figure 24. Europe Antidiabetic Drug Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Antidiabetic Drug Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Antidiabetic Drug Sales Market Share in Value by Type in 2025 Figure 27. Latin America Antidiabetic Drug Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Antidiabetic Drug Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Antidiabetic Drug Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Antidiabetic Drug Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Antidiabetic Drug Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Type I Diabetes Image Figure 34. Global Type I Diabetes Sales YoY Growth (2021-2032) & (K Units) Figure 35. Type II Diabetes Image Figure 36. Global Type II Diabetes Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Antidiabetic Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Antidiabetic Drug Market Share by Application 2025 VS 2032 Figure 39. North America Antidiabetic Drug Sales Market Share in Volume by Application in 2025 Figure 40. North America Antidiabetic Drug Sales Market Share in Value by Application in 2025 Figure 41. Europe Antidiabetic Drug Sales Market Share in Volume by Application in 2025 Figure 42. Europe Antidiabetic Drug Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Antidiabetic Drug Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Antidiabetic Drug Sales Market Share in Value by Application in 2025 Figure 45. Latin America Antidiabetic Drug Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Antidiabetic Drug Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Antidiabetic Drug Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Antidiabetic Drug Sales Market Share in Value by Application in 2025 Figure 49. North America Antidiabetic Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Antidiabetic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Antidiabetic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Antidiabetic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Antidiabetic Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Antidiabetic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Antidiabetic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Antidiabetic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Antidiabetic Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Antidiabetic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Antidiabetic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Antidiabetic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Antidiabetic Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Antidiabetic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Antidiabetic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Antidiabetic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Antidiabetic Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Antidiabetic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Antidiabetic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Antidiabetic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Antidiabetic Drug Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Antidiabetic Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Dpp-4 Inhibitors
  • Glp-1 Agonist
  • Alpha-Glucosidase Inhibitors
  • Sglt–2
  • Thiazolodinediones
  • Meglitinides
  • Biguanides, Sulphonylureas
Applications
  • Type I Diabetes
  • Type II Diabetes
Companies covered
  • Takeda
  • Eli Lilly
  • Pfizer
  • Wockhardt
  • Tonghua Dongbao
  • Sanofi-Aventis
  • Oramed
  • Novo Nordisk
  • Halozyme Therapeutics
  • Bristol-Myers Squibb
  • Boehringer Ingelheim
  • Biocon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antidiabetic Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antidiabetic Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antidiabetic Drug Market by Type
  6. 1.3.1 Dpp-4 Inhibitors
  7. 1.3.2 Glp-1 Agonist
  8. 1.3.3 Alpha-Glucosidase Inhibitors
  9. 1.3.4 Sglt–2
  10. 1.3.5 Thiazolodinediones
  11. 1.3.6 Meglitinides
  12. 1.3.7 Biguanides, Sulphonylureas
  13. 1.4 Global Antidiabetic Drug Market Size by Type
  14. 1.4.1 Global Antidiabetic Drug Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Antidiabetic Drug Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Antidiabetic Drug Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Antidiabetic Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Antidiabetic Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Antidiabetic Drug Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Antidiabetic Drug Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Antidiabetic Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antidiabetic Drug Industry Trends
  2. 2.2 Antidiabetic Drug Industry Drivers
  3. 2.3 Antidiabetic Drug Industry Opportunities and Challenges
  4. 2.4 Antidiabetic Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antidiabetic Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Antidiabetic Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Antidiabetic Drug Price (2021-2026)
  4. 3.4 Global Antidiabetic Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antidiabetic Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Antidiabetic Drug Company, Product Type & Application
  7. 3.7 Global Antidiabetic Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antidiabetic Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antidiabetic Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antidiabetic Drug Tier 1, Tier 2, and Tier 3
4 Antidiabetic Drug Regional Status and Outlook
  1. 4.1 Global Antidiabetic Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antidiabetic Drug Historic Market Size by Region
  3. 4.2.1 Global Antidiabetic Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antidiabetic Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antidiabetic Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antidiabetic Drug Forecasted Market Size by Region
  7. 4.3.1 Global Antidiabetic Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antidiabetic Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antidiabetic Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antidiabetic Drug by Application
  1. 5.1 Antidiabetic Drug Market by Application
  2. 5.1.1 Type I Diabetes
  3. 5.1.2 Type II Diabetes
  4. 5.2 Global Antidiabetic Drug Market Size by Application
  5. 5.2.1 Global Antidiabetic Drug Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Antidiabetic Drug Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Antidiabetic Drug Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Antidiabetic Drug Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Antidiabetic Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Antidiabetic Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Antidiabetic Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Antidiabetic Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Antidiabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Antidiabetic Drug Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Eli Lilly
  8. 6.2.1 Eli Lilly Company Information
  9. 6.2.2 Eli Lilly Business Overview
  10. 6.2.3 Eli Lilly Antidiabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eli Lilly Antidiabetic Drug Product Portfolio
  12. 6.2.5 Eli Lilly Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Antidiabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Antidiabetic Drug Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Wockhardt
  20. 6.4.1 Wockhardt Company Information
  21. 6.4.2 Wockhardt Business Overview
  22. 6.4.3 Wockhardt Antidiabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Wockhardt Antidiabetic Drug Product Portfolio
  24. 6.4.5 Wockhardt Recent Developments
  25. 6.5 Tonghua Dongbao
  26. 6.5.1 Tonghua Dongbao Company Information
  27. 6.5.2 Tonghua Dongbao Business Overview
  28. 6.5.3 Tonghua Dongbao Antidiabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Tonghua Dongbao Antidiabetic Drug Product Portfolio
  30. 6.5.5 Tonghua Dongbao Recent Developments
  31. 6.6 Sanofi-Aventis
  32. 6.6.1 Sanofi-Aventis Company Information
  33. 6.6.2 Sanofi-Aventis Business Overview
  34. 6.6.3 Sanofi-Aventis Antidiabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sanofi-Aventis Antidiabetic Drug Product Portfolio
  36. 6.6.5 Sanofi-Aventis Recent Developments
  37. 6.7 Oramed
  38. 6.7.1 Oramed Company Information
  39. 6.7.2 Oramed Business Overview
  40. 6.7.3 Oramed Antidiabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Oramed Antidiabetic Drug Product Portfolio
  42. 6.7.5 Oramed Recent Developments
  43. 6.8 Novo Nordisk
  44. 6.8.1 Novo Nordisk Company Information
  45. 6.8.2 Novo Nordisk Business Overview
  46. 6.8.3 Novo Nordisk Antidiabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Novo Nordisk Antidiabetic Drug Product Portfolio
  48. 6.8.5 Novo Nordisk Recent Developments
  49. 6.9 Halozyme Therapeutics
  50. 6.9.1 Halozyme Therapeutics Company Information
  51. 6.9.2 Halozyme Therapeutics Business Overview
  52. 6.9.3 Halozyme Therapeutics Antidiabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Halozyme Therapeutics Antidiabetic Drug Product Portfolio
  54. 6.9.5 Halozyme Therapeutics Recent Developments
  55. 6.10 Bristol-Myers Squibb
  56. 6.10.1 Bristol-Myers Squibb Company Information
  57. 6.10.2 Bristol-Myers Squibb Business Overview
  58. 6.10.3 Bristol-Myers Squibb Antidiabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Bristol-Myers Squibb Antidiabetic Drug Product Portfolio
  60. 6.10.5 Bristol-Myers Squibb Recent Developments
  61. 6.11 Boehringer Ingelheim
  62. 6.11.1 Boehringer Ingelheim Company Information
  63. 6.11.2 Boehringer Ingelheim Business Overview
  64. 6.11.3 Boehringer Ingelheim Antidiabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Boehringer Ingelheim Antidiabetic Drug Product Portfolio
  66. 6.11.5 Boehringer Ingelheim Recent Developments
  67. 6.12 Biocon
  68. 6.12.1 Biocon Company Information
  69. 6.12.2 Biocon Business Overview
  70. 6.12.3 Biocon Antidiabetic Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Biocon Antidiabetic Drug Product Portfolio
  72. 6.12.5 Biocon Recent Developments
7 North America by Country
  1. 7.1 North America Antidiabetic Drug Sales by Country
  2. 7.1.1 North America Antidiabetic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antidiabetic Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Antidiabetic Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antidiabetic Drug Market Size by Country
  6. 7.2.1 North America Antidiabetic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antidiabetic Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Antidiabetic Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antidiabetic Drug Sales by Country
  2. 8.1.1 Europe Antidiabetic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antidiabetic Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Antidiabetic Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antidiabetic Drug Market Size by Country
  6. 8.2.1 Europe Antidiabetic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antidiabetic Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antidiabetic Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antidiabetic Drug Sales by Country
  2. 9.1.1 Asia-Pacific Antidiabetic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antidiabetic Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antidiabetic Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antidiabetic Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Antidiabetic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antidiabetic Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antidiabetic Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antidiabetic Drug Sales by Country
  2. 10.1.1 South America Antidiabetic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antidiabetic Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Antidiabetic Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antidiabetic Drug Market Size by Country
  6. 10.2.1 South America Antidiabetic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antidiabetic Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Antidiabetic Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antidiabetic Drug Sales by Country
  2. 11.1.1 Middle East and Africa Antidiabetic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antidiabetic Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antidiabetic Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antidiabetic Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Antidiabetic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antidiabetic Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antidiabetic Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antidiabetic Drug Value Chain Analysis
  2. 12.1.1 Antidiabetic Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antidiabetic Drug Production Mode & Process
  7. 12.2 Antidiabetic Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antidiabetic Drug Distributors
  10. 12.2.3 Antidiabetic Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst